Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other financing activities (2020 - 2023)

Terns Pharmaceuticals' Other financing activities history spans 4 years, with the latest figure at $344000.0 for Q1 2023.

  • For Q1 2023, Other financing activities changed N/A year-over-year to $344000.0; the TTM value through Dec 2023 reached $344000.0, down 14.21%, while the annual FY2025 figure was $235000.0, 39.43% down from the prior year.
  • Other financing activities reached $344000.0 in Q1 2023 per TERN's latest filing, up from $257000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.7 million in Q2 2021 to a low of $33000.0 in Q1 2020.
  • Average Other financing activities over 4 years is $617714.3, with a median of $344000.0 recorded in 2023.
  • The largest YoY upside for Other financing activities was 3024.24% in 2021 against a maximum downside of 3024.24% in 2021.
  • A 4-year view of Other financing activities shows it stood at $825000.0 in 2020, then soared by 104.85% to $1.7 million in 2021, then plummeted by 84.79% to $257000.0 in 2022, then soared by 33.85% to $344000.0 in 2023.
  • Per Business Quant, the three most recent readings for TERN's Other financing activities are $344000.0 (Q1 2023), $257000.0 (Q4 2022), and $144000.0 (Q3 2022).